Efficacy of online psychoeducation and relaxation training program (OnPR) on mental health problems in COVID-19 patients: A randomized controlled trial

被引:2
|
作者
Chinvararak, Chotiman [1 ]
Kirdchok, Pantri [1 ]
Wonglertwisawakorn, Chayut [1 ]
Pumjun, Pachara [2 ]
Kerdcharoen, Nitchawan [1 ,3 ]
机构
[1] Navamindradhiraj Univ, Fac Med, Dept Psychiat, Vajira Hosp, Bangkok, Thailand
[2] Navamindradhiraj Univ, Fac Med, Dept Urban Med, Vajira Hosp, Bangkok, Thailand
[3] 681 Samsen Rd, Bangkok 10300, Thailand
关键词
Online; Psychoeducation; Relaxation training; Mental health problems; COVID-19; Randomized controlled trial; SLEEP QUALITY INDEX; SEVERITY; VALIDITY;
D O I
10.1016/j.invent.2023.100705
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Purpose: Prior studies found that the prevalence of anxiety, depression, stress and insomnia were relatively high in COVID-19 patients. This study aimed to explore the efficacy of OnPR on mental health outcomes in patients with asymptomatic or mildly symptomatic COVID-19. Patients and methods: We employed a randomized controlled trial following the CONSORT guidelines. The Thai Clinical Trials Registry identification number of this study is TCTR20220729003. We used a block of 4 randomizations generated by a computer program. The intervention group (n = 38) received the OnPR program, and the control group (n = 36) received care as usual. OnPR was an online psychological intervention comprising psychoeducation, sleep hygiene education and relaxation techniques. OnPR was provided by qualified therapists trained with a standard protocol. The primary outcomes were depression, anxiety, and stress, which were determined by the Depression Anxiety and Stress Scale-21 (DASS-21). Sleep quality was measured by the Pittsburgh Sleep Quality Index (PSQI). Outcomes were compared between groups at pre-intervention and postintervention at 1, 4, and 12 weeks using paired t -test or Wilcoxon signed-rank test. In addition, a linear mixed model was employed to demonstrate the effect changes of OnPR over time. All analyses were two-tailed, with a significance level of 0.05. Results: Of 74 Thai participants, 89.2 % were female, and 11.8 % were male. The average age was 31 years. Participants' baseline characteristics were not statistically significant between the intervention and control groups except for depression and stress scores from DASS-21. OnPR resulted in significantly better improvement in depression, anxiety, stress, and sleep quality. The mean differences between groups of DASS-21 scores in depression, anxiety and stress at 7-day follow-up were -4.69, -3.29, and -5.50 respectively. The differences continue to be significant at 4-week and 12-week follow-ups. The mean difference between groups of PSQI at 7day follow-up is -0.91. Conclusion: OnPR improved mental health outcomes, and the effect on depression, anxiety and stress lasted for at least a 12-week follow-up period. In addition, it could enhance sleep quality after the intervention.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] On the Efficacy of a CBT-I-Based Online Program for Sleep Problems: A Randomized Controlled Trial
    Eigl, Esther-Sevil
    Hauser, Theresa
    Topalidis, Pavlos I.
    Schabus, Manuel
    CLOCKS & SLEEP, 2023, 5 (04): : 590 - 603
  • [32] Efficacy of an asynchronous telerehabilitation program in post-COVID-19 patients: A protocol for a pilot randomized controlled trial
    Carpallo-Porcar, Beatriz
    Romo-Calvo, Laura
    Perez-Palomares, Sara
    Jimenez-Sanchez, Carolina
    Herrero, Pablo
    Brandin-de La Cruz, Natalia
    Calvo, Sandra
    PLOS ONE, 2022, 17 (07):
  • [33] Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial
    de Pinho, Lara Manuela Guedes
    Sequeira, Carlos Alberto da Cruz
    Sampaio, Francisco Miguel Correia
    Rocha, Nuno Barbosa
    Ozaslan, Zeynep
    Ferre-Grau, Carmen
    JOURNAL OF ADVANCED NURSING, 2021, 77 (02) : 999 - 1012
  • [34] The Efficacy of "Foundations," a Digital Mental Health App to Improve Mental Well-being During COVID-19: Proof-of-Principle Randomized Controlled Trial
    Catuara-Solarz, Silvina
    Skorulski, Bartlomiej
    Estella-Aguerri, Inaki
    Avella-Garcia, Claudia Bibiana
    Shepherd, Sarah
    Stott, Emily
    Hemmings, Nicola R.
    de Villa, Aleix Ruiz
    Schulze, Laura
    Dix, Sophie
    JMIR MHEALTH AND UHEALTH, 2022, 10 (07):
  • [35] Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial
    Ali Ameri
    Mehdi Farashahinejad
    Parivash Davoodian
    Omid Safa
    Amin Kusha
    Habib Dadvand
    Soheil Hassanipour
    Mohammad Fathalipour
    Inflammopharmacology, 2023, 31 : 3037 - 3045
  • [36] Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial
    Zurita-Cruz, Jessie
    Fonseca-Tenorio, Jeffry
    Villasis-Keever, Miguel
    Lopez-Alarcon, Mardia
    Parra-Ortega, Israel
    Lopez-Martinez, Briceida
    Miranda-Novales, Guadalupe
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [37] Efficacy and safety of deferoxamine in moderately ill COVID-19 patients: An open label, randomized controlled trial
    Ameri, Ali
    Pourseyedi, Farnaz
    Davoodian, Parivash
    Safa, Omid
    Hassanipour, Soheil
    Fathalipour, Mohammad
    MEDICINE, 2024, 103 (34)
  • [38] The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
    Shohan, Mojtaba
    Nashibi, Roohangiz
    Mahmoudian-Sani, Mohammad-Reza
    Abolnezhadian, Farhad
    Ghafourian, Mehri
    Alavi, Seyed Mohammad
    Sharhani, Asaad
    Khodadadi, Ali
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 914
  • [39] Thought Field Therapy intervention to improve mental health during the COVID-19 pandemic: A randomized controlled trial
    Morikawa, Ayame
    Fujimoto, Masaki
    Kawagishi, Yuriko
    Fukagawa, Tomiyo
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2025, 21 (02)
  • [40] Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial
    Ameri, Ali
    Farashahinejad, Mehdi
    Davoodian, Parivash
    Safa, Omid
    Kusha, Amin
    Dadvand, Habib
    Hassanipour, Soheil
    Fathalipour, Mohammad
    INFLAMMOPHARMACOLOGY, 2023, 31 (06) : 3037 - 3045